Inhibition of Histone Lysine-specific Demethylase 1 Elicits Breast Tumor Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade

Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective strategies to overcome resistance to immunotherapy are urgently needed. In this study, we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Ye, Vasilatos, Shauna N., Chen, Lin, Wu, Hao, Cao, Zhishen, Fu, Yumei, Huang, Min, Vlad, Anda M., Lu, Binfeng, Oesterreich, Steffi, Davidson, Nancy E., Huang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336685/
https://www.ncbi.nlm.nih.gov/pubmed/30111819
http://dx.doi.org/10.1038/s41388-018-0451-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336685/
https://www.ncbi.nlm.nih.gov/pubmed/30111819
http://dx.doi.org/10.1038/s41388-018-0451-5

Ejemplares similares